Steven J Collins

Title: The Innovations of Steven J Collins

Introduction

Steven J Collins is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of molecular biology, particularly in the study of polynucleotide molecules and their applications in cancer research. With a total of 2 patents, Collins has established himself as a key figure in his area of expertise.

Latest Patents

Collins' latest patents include groundbreaking work on isolated polynucleotide molecules encoding CTCF, a CCCTC-binding factor. These polynucleotide molecules are isolated, purified, and sequenced, allowing for the identification of mutant CTCFs in diagnostic methods. Another significant patent involves creating novel hematopoietic cell lines by expressing altered retinoic acid, which has potential implications in cancer treatment and research.

Career Highlights

Throughout his career, Collins has worked with prestigious organizations such as the Fred Hutchinson Cancer Center and Cancer Research Campaign Technology Limited. His work at these institutions has contributed to advancements in cancer research and therapeutic development.

Collaborations

Collins has collaborated with esteemed colleagues, including Schickwann Tsai and Victor L Lobanenkov. These partnerships have fostered innovation and have been instrumental in the progress of their shared research goals.

Conclusion

Steven J Collins is a prominent inventor whose work in molecular biology has led to significant advancements in cancer research. His patents and collaborations reflect his dedication to improving diagnostic and therapeutic methods in the field.